Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-19,024
Closed -$4.5M 60
2019
Q1
$4.5M Sell
19,024
-162
-0.8% -$51K 1.33% 37
2018
Q4
$5.77M Sell
19,186
-761
-4% -$243K 1.91% 25
2018
Q3
$7.05M Sell
19,947
-783
-4% -$270K 1.97% 23
2018
Q2
$6.02M Buy
20,730
+1,200
+6% +$337K 1.75% 30
2018
Q1
$5.35M Buy
19,530
+210
+1% +$65.2K 1.64% 33
2017
Q4
$6.15M Sell
19,320
-1,145
-6% -$367K 1.86% 28
2017
Q3
$6.41M Buy
20,465
+150
+0.7% +$44.4K 1.92% 24
2017
Q2
$5.51M Sell
20,315
-155
-0.8% -$41K 1.69% 29
2017
Q1
$5.6M Buy
20,470
+2,550
+14% +$721K 1.7% 30
2016
Q4
$5.08M Buy
17,920
+240
+1% +$71.1K 1.83% 27
2016
Q3
$5.53M Buy
17,680
+5,685
+47% +$1.68M 2.03% 16
2016
Q2
$2.9M Buy
11,995
+10,615
+769% +$2.8M 1.1% 42
2016
Q1
$359K Buy
+1,380
New +$365K 0.14% 61

Other funds holding BIIB

Evelyn V. Moreno's BIIB Position: Q2 2019 in Review

Evelyn V. Moreno sold out of Biogen (BIIB) in Q2 2019, closing a stake of 19,024 shares — an estimated $4.5M sold.

Evelyn V. Moreno first reported a position in BIIB in Q1 2016 and held it in 13 quarters. The position peaked at $7.05M in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Evelyn V. Moreno reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Evelyn V. Moreno sold 19,024 Biogen shares in Q2 2019, an estimated $4.5M.
  • Evelyn V. Moreno first reported a position in Biogen in Q1 2016 and held it in 13 quarters.
  • Evelyn V. Moreno's Biogen position peaked at $7.05M in Q3 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Evelyn V. Moreno's 13F filing for Q2 2019, filed 1 Aug 2019.